1H
-1.93%$3.06
24H
-7.18%$12.03
7D
-12.8%$22.87
30D
-12.9%$23.06
The $159 level is a key support to watch for Aave (AAVE), while a break below could send prices toward $128.
Aave has proven to users that DeFi protocols can now handle liquidations in the face of market distress.
Is the short-term scare turning whales into paper-hands or is a downfall coming for the top DeFi tokens?
Aave’s testnet deployment on Aptos aims to assess V3’s safety and performance, with mainnet launch pending governance approval.
The bullish performance of AAVE over the past month is at risk as sellers take over the market. As uncertainties grow, will the AAVE bull run take a plunge under $300 or continue to grow? Whales remain crucial.
Aave is a decentralized finance protocol that allows people to lend and borrow crypto.
Lenders earn interest by depositing digital assets into specially created liquidity pools. Borrowers can then use their crypto as collateral to take out a flash loan using this liquidity.
Aave (which means “ghost” in Finnish) was originally known as ETHLend when it launched in November 2017, but the rebranding to Aave happened in September 2018. (This helps explain why this token’s ticker is so different from its name!)
AAVE provides holders with discounted fees on the platform, and it also serves as a governance token – giving owners a say in the future development of the protocol.
The below guide describes crypto index funds – the upgraded version of traditional index funds. They present investors with an investment plan that simultaneously gives a high ROI and mitigates the risk of investing in a particular crypto.
Here’s an overview of the top 10 biotech and pharmaceutical stocks to watch in 2020. This biotech stocks list consists of companies that are actively developing drugs to fight diseases and even the coronavirus pandemic.
